To explore the potential mechanisms of HTR2A and HTR2B as prognostic biomarkers for breast cancer, we analyzed the association between these two HTR receptors and immune cell infiltration in the tumor microenvironment through the TIMER database (Figure 7A). The gene discussed is HTR2B; the disease is breast carcinoma.